News & Events
Clinical Trials Review in Russia (January 2023)
Data review for January showed a traditional decrease in the number of approved drug clinical trials in the first month of the new calendar year compared to December of the previous year (by 21%). At the same time, the decline in the indicator during the period of 2022–2023 turned out to be less abrupt than, for example, last year, when the number of approved clinical trials in January 2022 compared to December 2021 decreased by more than 2.5 times. Details
Data review for January showed a traditional decrease in the number of approved drug clinical trials in the first month of the new calendar year compared to December of the previous year (by 21%). At the same time, the decline in the indicator during the period of 2022–2023 turned out to be less abrupt than, for example, last year, when the number of approved clinical trials in January 2022 compared to December 2021 decreased by more than 2.5 times. Details
Clinical Trials Review in Russia (December 2022)
Data review on approved drug clinical trials for December showed no significant differences from the results of the previous month, while at the same time, compared to the same period in 2021, the number of approvals for trials issued by the Ministry of Health of the Russian Federation decreased exactly by half. Details
Data review on approved drug clinical trials for December showed no significant differences from the results of the previous month, while at the same time, compared to the same period in 2021, the number of approvals for trials issued by the Ministry of Health of the Russian Federation decreased exactly by half. Details
Clinical Trials Review in Russia (November 2022)
Data review of approved drug clinical trials in November 2022 showed no changes in the number of clinical trials compared to the previous month, at the same time, compared to the same period in 2021, the total number of trials initiated in November decreased by 46%. Details
Data review of approved drug clinical trials in November 2022 showed no changes in the number of clinical trials compared to the previous month, at the same time, compared to the same period in 2021, the total number of trials initiated in November decreased by 46%. Details
Clinical Trials Review in Russia (October 2022)
Data review for October 2022 showed a slight decrease in the number of approved drug clinical trials compared to the previous month and more noticeable changes compared to the same period in 2021 - a decrease in the total number of clinical trials by 1.7 times. Details
Data review for October 2022 showed a slight decrease in the number of approved drug clinical trials compared to the previous month and more noticeable changes compared to the same period in 2021 - a decrease in the total number of clinical trials by 1.7 times. Details
Clinical Trials Review in Russia (September 2022)
In September 2022, there was a slight increase in the number of approved drug clinical trials compared to the previous month and a sharp decrease in the number of clinical trials compared to the same period in 2021 (more than 2 times). Details
In September 2022, there was a slight increase in the number of approved drug clinical trials compared to the previous month and a sharp decrease in the number of clinical trials compared to the same period in 2021 (more than 2 times). Details
Clinical Trials Review in Russia (August 2022)
In August 2022, a decrease in the total number of approved drug clinical trials was registered compared to the same period in 2021, while at the same time, there were no significant changes in this indicator compared to July 2022. Details
In August 2022, a decrease in the total number of approved drug clinical trials was registered compared to the same period in 2021, while at the same time, there were no significant changes in this indicator compared to July 2022. Details
Clinical Trials Review in Russia (July 2022)
In July 2022, there was a decrease in the number of approved drug clinical trials by 23% compared to the previous month and by 40% compared to July 2021. Details
In July 2022, there was a decrease in the number of approved drug clinical trials by 23% compared to the previous month and by 40% compared to July 2021. Details
Clinical Trials Review in Russia (June 2022)
Data review of clinical trials for June 2022 showed an increase in the total number of approved drug clinical trials compared to the previous month and almost no change compared to the same period in 2021. Details
Data review of clinical trials for June 2022 showed an increase in the total number of approved drug clinical trials compared to the previous month and almost no change compared to the same period in 2021. Details
Clinical Trials Review in Russia (May 2022)
Data review on clinical trials in May showed a sharp decrease in the number of approved drug clinical trials both compared to the past months of 2022 (especially compared to April of the current year) and compared to most months of 2021. In May 2022, the smallest number of permits for CT was issued in the last 12 months of 2021–2022. (43 trials). At the same time, it should be noted that the minimum indicator for 2021 in terms of the total number of approved clinical trials was also in May 2021 - 29 clinical trials). Details
Data review on clinical trials in May showed a sharp decrease in the number of approved drug clinical trials both compared to the past months of 2022 (especially compared to April of the current year) and compared to most months of 2021. In May 2022, the smallest number of permits for CT was issued in the last 12 months of 2021–2022. (43 trials). At the same time, it should be noted that the minimum indicator for 2021 in terms of the total number of approved clinical trials was also in May 2021 - 29 clinical trials). Details
Clinical Trials Review in Russia (April 2022)
Data review on clinical trials in April 2022 showed a significant increase in the number of approved drug clinical trials both compared to the previous month and compared to the same period in 2021. Details
Data review on clinical trials in April 2022 showed a significant increase in the number of approved drug clinical trials both compared to the previous month and compared to the same period in 2021. Details
Clinical Trials Review in Russia (March 2022)
Data review for March 2022 showed a times 1.4 decrease in the number of approved clinical trials of medicines compared to the previous month and a slight increase in the number of approved clinical trials compared to the same period in 2021. Details
Data review for March 2022 showed a times 1.4 decrease in the number of approved clinical trials of medicines compared to the previous month and a slight increase in the number of approved clinical trials compared to the same period in 2021. Details
Clinical Trials Review in Russia (February 2022)
Data review for February 2022 demonstrated a sharp increase in the number of approved drug clinical trials both compared to the previous month and compared to February 2021. Details
Data review for February 2022 demonstrated a sharp increase in the number of approved drug clinical trials both compared to the previous month and compared to February 2021. Details
Clinical Trials Review in Russia (2021)
In 2021, 908 medical device clinical trials were approved, which is 19% higher than in 2020 (734 trials) and slightly higher than in 2016 (898 trials), when the largest number of studies have been registered so far per year. Details
In 2021, 908 medical device clinical trials were approved, which is 19% higher than in 2020 (734 trials) and slightly higher than in 2016 (898 trials), when the largest number of studies have been registered so far per year. Details
Clinical Trials Review in Russia (January 2022)
Data review in January 2022 showed a sharp decrease in the number of approved drug clinical trials compared to the previous month and insignificant changes compared to the first month of 2021. Details
Data review in January 2022 showed a sharp decrease in the number of approved drug clinical trials compared to the previous month and insignificant changes compared to the first month of 2021. Details
Clinical Trials Review in Russia (November 2021)
Data review on clinical trials in November 2021 shows a slight increase in the number of approved drug clinical trials compared to the previous month and a significant increase compared to the same period in 2020 (in November 2021, 1.75 times more drug clinical trials were approved than in November 2020). Details
Data review on clinical trials in November 2021 shows a slight increase in the number of approved drug clinical trials compared to the previous month and a significant increase compared to the same period in 2020 (in November 2021, 1.75 times more drug clinical trials were approved than in November 2020). Details
Clinical Trials Review in Russia (October 2021)
Data review on clinical trials in October 2021 shows a significant decrease in the number of approved clinical trials compared to the previous month (in September 2021, a historic maximum was registered in the number of clinical trials - 114 initiations), but at the same time, an increase in the number compared to with the same period in 2020. Details
Data review on clinical trials in October 2021 shows a significant decrease in the number of approved clinical trials compared to the previous month (in September 2021, a historic maximum was registered in the number of clinical trials - 114 initiations), but at the same time, an increase in the number compared to with the same period in 2020. Details
Clinical Trials Review in Russia (September 2021)
Data review on clinical trials in September 2021 demonstrates noticeable increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. In September 2021, the maximum number of trials per month was recorded for the entire observation period (2013–2021), which amounted to 114 trials (in previous years, this indicator did not exceed 100 initiations). Details
Data review on clinical trials in September 2021 demonstrates noticeable increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. In September 2021, the maximum number of trials per month was recorded for the entire observation period (2013–2021), which amounted to 114 trials (in previous years, this indicator did not exceed 100 initiations). Details
Clinical Trials Review in Russia (August 2021)
Data review on clinical trials in August 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. Details
Data review on clinical trials in August 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month together with the corresponding period of 2020. Details
Clinical Trials Review in Russia (July 2021)
Data review on clinical trials in July 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Data review on clinical trials in July 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (June 2021)
Data review on clinical trials in June 2021 demonstrates more than a double increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Data review on clinical trials in June 2021 demonstrates more than a double increase in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (May 2021)
Data review on clinical trials in May 2021 demonstrates strong decrease in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Data review on clinical trials in May 2021 demonstrates strong decrease in the number of approved drug clinical trials compared to the previous month and slight decrease compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (April 2021)
Data review on clinical trials in April 2021 demonstrates slight decrease in the number of approved drug clinical trials compared to the previous month and the noticeable increase compared to the corresponding period of 2020. Details
Data review on clinical trials in April 2021 demonstrates slight decrease in the number of approved drug clinical trials compared to the previous month and the noticeable increase compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (March 2021)
Data review on clinical trials in March 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and the increase compared to the corresponding period of 2020. Details
Data review on clinical trials in March 2021 demonstrates increase in the number of approved drug clinical trials compared to the previous month and the increase compared to the corresponding period of 2020. Details
Clinical Trials Review in Russia (February 2021)
Data review on clinical trials in February 2021 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and the increase compared with the corresponding period of 2020. Details
Data review on clinical trials in February 2021 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and the increase compared with the corresponding period of 2020. Details
Clinical Trials Review in Russia (January 2021)
Data review on clinical trials in January 2021 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and increase compared with the corresponding period of 2020. Details
Data review on clinical trials in January 2021 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and increase compared with the corresponding period of 2020. Details
Clinical Trials Review in Russia (December 2020)
Data review on clinical trials in December 2020 demonstrates increase in the number of approved drug clinical trials compared with the previous month and also with the corresponding period of 2019. Details
Data review on clinical trials in December 2020 demonstrates increase in the number of approved drug clinical trials compared with the previous month and also with the corresponding period of 2019. Details
Clinical Trials Review in Russia (November 2020)
Data review on clinical trials in November 2020 demonstrates moderate decrease in the number of approved drug clinical trials compared with the previous month and slight increase of this number compared with the corresponding period of 2019. Details
Data review on clinical trials in November 2020 demonstrates moderate decrease in the number of approved drug clinical trials compared with the previous month and slight increase of this number compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (October 2020)
Data review on clinical trials in October 2020 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and remains unchanged compared with the corresponding period of 2019. Details
Data review on clinical trials in October 2020 demonstrates slight decrease in the number of approved drug clinical trials compared with the previous month and remains unchanged compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (September 2020)
Data review on clinical trials in September 2020 demonstrates increase in the number of approved drug clinical trials compared with the previous month and a slight decrease compared with the corresponding period of 2019. Details
Data review on clinical trials in September 2020 demonstrates increase in the number of approved drug clinical trials compared with the previous month and a slight decrease compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (August 2020)
Data review on clinical trials in August 2020 demonstrates decrease in the number of approved drug clinical trials compared with the previous month and a slight increase compared with the corresponding period of 2019. Details
Data review on clinical trials in August 2020 demonstrates decrease in the number of approved drug clinical trials compared with the previous month and a slight increase compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (July 2020)
Data review on clinical trials in July 2020 shows increase in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Data review on clinical trials in July 2020 shows increase in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Clinical Trials Review in Russia (June 2020)
Data review on clinical trials in June 2020 shows doubled increase in the number of approved drug clinical trials compared with the previous month and a slight increase compared with the corresponding period of 2019. Details
Data review on clinical trials in June 2020 shows doubled increase in the number of approved drug clinical trials compared with the previous month and a slight increase compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (May 2020)
Data review on clinical trials in May 2020 shows significant decrease in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Data review on clinical trials in May 2020 shows significant decrease in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Clinical Trials Review in Russia (April 2020)
Data review on clinical trials in April 2020 shows a significant decrease in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Data review on clinical trials in April 2020 shows a significant decrease in the number of approved drug clinical trials compared with the previous month together with the corresponding period of 2019. Details
Clinical Trials Review in Russia (March 2020)
Data review on clinical trials in March 2020 shows a slight increase in the number of approved drug clinical trials compared with the previous month together with a slight decrease compared with the corresponding period of 2019. Details
Data review on clinical trials in March 2020 shows a slight increase in the number of approved drug clinical trials compared with the previous month together with a slight decrease compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (February 2020)
Data review on clinical trials in February 2020 shows a significant increase in the number of approved drug clinical trials compared with the previous month together with a slight growth compared with the corresponding period of 2019. Details
Data review on clinical trials in February 2020 shows a significant increase in the number of approved drug clinical trials compared with the previous month together with a slight growth compared with the corresponding period of 2019. Details
Clinical Trials Review in Russia (January2019)
Data review on clinical trials in January 2020 shows significant decrease in the number of approved drug clinical trials compared with the previous month as well as compared with the corresponding period of 2019. Details
Data review on clinical trials in January 2020 shows significant decrease in the number of approved drug clinical trials compared with the previous month as well as compared with the corresponding period of 2019. Details
Learn about clinical trials in Russia in 8 minutes!
New concept of short review «Сlinical trials in Russia within 2014-2019» Details
New concept of short review «Сlinical trials in Russia within 2014-2019» Details
Clinical Trials Review in Russia (December 2019)
Data review on clinical trials in December 2019 shows increase in the number of approved drug clinical trials compared with the previous month, as well as with the corresponding period of the year of 2018. Details
Data review on clinical trials in December 2019 shows increase in the number of approved drug clinical trials compared with the previous month, as well as with the corresponding period of the year of 2018. Details
Clinical Trials Review in Russia (November 2019)
Data review on clinical trials in November 2019 shows a moderate decrease in the number of approved drug clinical trials compared with the previous month, and it remains unchanged compared with the corresponding period of the year of 2018. Details
Data review on clinical trials in November 2019 shows a moderate decrease in the number of approved drug clinical trials compared with the previous month, and it remains unchanged compared with the corresponding period of the year of 2018. Details
Clinical Trials Review in Russia (October 2019)
Data review on clinical trials in October 2019 shows a significant decrease in the number of approved drug clinical trials compared with the previous month, and a slight increase compared with the corresponding period of 2018. Details
Data review on clinical trials in October 2019 shows a significant decrease in the number of approved drug clinical trials compared with the previous month, and a slight increase compared with the corresponding period of 2018. Details
Clinical Trials Review in Russia (September 2019)
Data review on clinical trials in September 2019 shows a significant increase in the number of approved drug clinical trials compared with the previous month as well as compared with the corresponding period of 2018. Details
Data review on clinical trials in September 2019 shows a significant increase in the number of approved drug clinical trials compared with the previous month as well as compared with the corresponding period of 2018. Details
Clinical Trials Review in Russia (March 2018)
Data review on clinical trials in March 2018 showed a slight increase in the number of approved drug trials compared with the previous month and a slight decrease in the number of clinical trials compared with the corresponding period of 2017. Details
Data review on clinical trials in March 2018 showed a slight increase in the number of approved drug trials compared with the previous month and a slight decrease in the number of clinical trials compared with the corresponding period of 2017. Details
Clinical Trials Review in Russia (February 2018)
Data review on clinical trials in February 2018 showed a significant increase in the number of approved drug clinical trials compared with the previous month and a slight decrease in the number of approved clinical trials compared with the corresponding period of 2017. Details
Data review on clinical trials in February 2018 showed a significant increase in the number of approved drug clinical trials compared with the previous month and a slight decrease in the number of approved clinical trials compared with the corresponding period of 2017. Details
The EAEU & CIS Pharmaceutical Forum
The EAEU & CIS Pharmaceutical Forum 2018 was held in Moscow on February 27-28 with the sponsorship of Sciencefiles LLC. Details
The EAEU & CIS Pharmaceutical Forum 2018 was held in Moscow on February 27-28 with the sponsorship of Sciencefiles LLC. Details
Clinical Trials Review in Russia (January 2018)
Data review in January 2018 showed a significant decrease in the number of approved drug clinical trials compared with the previous month and the corresponding period of 2017. Details
Data review in January 2018 showed a significant decrease in the number of approved drug clinical trials compared with the previous month and the corresponding period of 2017. Details
Announcement of the EEU & CIS Pharmaceutical Forum 2017
On February 27-28 in Moscow, with our sponsorship, the Pharmaceutical Forum of the CIS and EEU 2018 will be held. Details
On February 27-28 in Moscow, with our sponsorship, the Pharmaceutical Forum of the CIS and EEU 2018 will be held. Details
Clinical Trials Review in Russia (2017)
In 2017, 700 clinical trials were approved, which was considerably less compared with the previous two years. Details
In 2017, 700 clinical trials were approved, which was considerably less compared with the previous two years. Details
Clinical Trials Review in Russia (November 2017)
Data review on clinical trials in November 2017 showed a slight decrease in the number of approved drug clinical trials compared with the previous month of the year and a significant decrease compared with the corresponding period of 2016. Details
Data review on clinical trials in November 2017 showed a slight decrease in the number of approved drug clinical trials compared with the previous month of the year and a significant decrease compared with the corresponding period of 2016. Details
Clinical Trials Review in Russia (October 2017)
Data review on clinical trials in October 2017 showed an increase in the number of approved drug clinical trials compared with the previous month. Details
Data review on clinical trials in October 2017 showed an increase in the number of approved drug clinical trials compared with the previous month. Details
Clinical Trials in Russia (September 2017)
Data analysis for September 2017 showed a small decrease in the number of approved clinical trials compared with the last month and the minimum number of studies compared with the same period in 2013-2016.
Details
Clinical Trials in Russia (August 2017)
Data analysis for August 2017 showed a small decrease in the number of approved clinical trials compared with the last month and the minimum number of studies compared with the same period in 2013-2016.
Details
Clinical Trials in Russia (July 2017)
Data analysis for July 2017 showed a small decrease in the number of approved clinical trials compared with the last month and dramatic decrease compared with the same period in 2016.
Details
Clinical Trials in Russia (June 2017)
Data analysis for June 2017 showed a small increase in the number of approved clinical trials compared with the last month and decrease compared with the same period in 2016.
Details
Clinical Trials in Russia (May 2017)
Data analysis for May 2017 showed that the number of approved clinical trials (57 clinical trials) did not change in comparison with the last month.
Details
Clinical Trials in Russia (April 2017)
Data analysis for April 2017 showed a small decrease in number of approved clinical trials.
Details
News from RegLek-EAEU-2017 Conference
At the end of April, our company participated in the conference RegLek-EAEU-2017 (Moscow). It was reported there that on May 6, 2017 Eurasian Economic Union main documents concerning the registration of medicines and medical products will take effect.
Details
Clinical Trials in Russia (March 2017)
Data analysis for March 2017 showed no change compared with the last month and decrease in number of approved clinical trials compared with the same period in 2016
Details
Clinical Trials in Russia (Febrary 2017)
Data analysis for February 2017 showed a small increase in number of approved clinical trials compared with the last month and decrease compared with the same period in 2016
Details
Clinical Trials in Russia (January 2017)
Data analysis for January 2017 showed a decrease in number of approved clinical trials compared with the last month and with the same period in 2016
Details
Clinical Trials in Russia (December 2016)
Data analysis for December 2016 showed a small increase in number of approved clinical trials compared with the last month and an expressed decrease compared with the same period in 2015.
Details
Clinical Trials in Russia (November 2016)
Data analysis for November 2016 showed a small decrease in number of approved clinical trials compared with the last month and an expressed decrease compared with the same period in 2015.
Details
Clinical Trials in Russia (October 2016)
Data analysis for October 2016 showed a small decrease in number of approved clinical trials compared with the last month and a little decrease compared with the same period in 2015.
Details
We’re 7
Dear colleagues and partners!
We’re pleased to inform you that 19 November 2016 we’ll celebrate our 7th anniversary!
Clinical Trials in Russia (September 2016)
Data analysis for September 2016 showed a small decrease in number of approved clinical trials compared with the last month and almost the same results compared with the same period in 2015.
Details
Clinical Trials in Russia (August 2016)
Data analysis for August 2016 showed a small decrease in number of approved clinical trials compared with the last month and dramatic increase compared with the same period in 2015.
Details
Clinical Trials in Russia (July 2016)
Data analysis for July 2016 showed a small decrease in number of approved clinical trials compared with the last month and marked increase compared with the same period in 2015.
Details
Clinical Trials in Russia (June 2016)
Data analysis for June 2016 showed a marked increase in approved drug clinical trial numbers compared with the last month and a little bit less of a dramatic increase compared with the same period in 2015.
Details
Clinical Trials in Russia (May 2016)
Data analysis for May 2016 showed a minor decrease in the number of approved clinical trials compared with the previous month and a marked increase compared with the same period in 2015.
Details
Clinical Trials in Russia (April 2016)
Data analysis for April 2016 showed a minor decrease in the number of approved clinical trials compared with the previous month and with the same period in 2015.
Details